受伤
发表于 2025-3-23 09:53:04
Smoothing a Critical TransitionRadiotherapy is the usual treatment for inoperable esophageal carcinoma. Results published before 1976, when this trial was begun were very modest, except for those of Pearson , The 1-year survival rate varies from 15% to 30%, and 5-year survival rates were about 5% .
绝食
发表于 2025-3-23 14:28:08
Smoothness Priors Analysis of Time SeriesIn an attempt to improve the conservative treatment of inoperable esophageal cancer we began 10 years ago to use the combined chemo-radiotherapy approach. Before conducting clinical trials we investigated the interaction of cytostatics and radiation in vitro on various cell lines.
antecedence
发表于 2025-3-23 19:35:08
http://reply.papertrans.cn/24/2301/230075/230075_13.png
赤字
发表于 2025-3-23 22:10:34
http://reply.papertrans.cn/24/2301/230075/230075_14.png
Ergots
发表于 2025-3-24 05:49:35
http://reply.papertrans.cn/24/2301/230075/230075_15.png
过于光泽
发表于 2025-3-24 10:25:41
Controlled Clinical Trial for the Treatment of Patients with Inoperable Esophageal Carcinoma: A StudRadiotherapy is the usual treatment for inoperable esophageal carcinoma. Results published before 1976, when this trial was begun were very modest, except for those of Pearson , The 1-year survival rate varies from 15% to 30%, and 5-year survival rates were about 5% .
lethal
发表于 2025-3-24 11:32:41
http://reply.papertrans.cn/24/2301/230075/230075_17.png
你正派
发表于 2025-3-24 18:34:42
Phase-III Clinical Trial of Adjuvant FAM2 (5-FU, Adriamycin and Mitomycin C) vs Control in ResectablDespite a reported decrease in incidence, gastric carcinoma remains a major oncologic problem in Western Europe. Surgery is at present the only hope for cure. The 5-year survival after curative surgery is about 40% for stage 2 and 20% for stage 3.
粗糙
发表于 2025-3-24 19:30:02
http://reply.papertrans.cn/24/2301/230075/230075_19.png
Encoding
发表于 2025-3-25 00:20:02
Preoperative Radiotherapy and Radical Surgery as Combined Treatment in Rectal CancerIn 1976, the Gastrointestinal Group of the EORTC activated a clinical trial on rectal cancer with the aim of studying the efficacy of high-dose preoperative irradiation therapy (34.5 Gy) as an adjuvant before radical surgery. This was a multicentric prospective phase-III clinical trial.